Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 11, 2000

View Archived Issues

Grant awarded to Cel-Sci for herpes simplex vaccine development

Recent work reveals central role for SLPI protein in healing

A20 protein found to be key mediator of inflammatory processes

FeRx receives grant for magnetic targeting of radioactive microparticles

Cubist reaches milestone in Novartis collaboration

New therapeutic approach to AD licensed by Neurogenetics

Affymetrix forms new genomics company

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Starlix receives first European approval for type 2 diabetes

Connetics' phase III human relaxin trial for scleroderma falls short of primary endpoint

Micellar paclitaxel shows good safety and tolerability in phase I

Roche begins E.U. launch for Herceptin

Bayer investigates inhibition of hepatic glycogen phosphorylase as therapy for type 2 diabetes

Rationally designed HIV protease inhibitors with improved pharmacokinetic properties

Systemic recombinant human relaxin stimulates wound healing in rat models

Antiinflammatory activity of green tea extracts reported in Hot Springs

Role for rho kinase inhibitors in the management of ED

RSV subunit vaccine successfully proceeds through clinical trials

Vaccine for preventing UTIs in early clinical trials at MedImmune

Investigational treatment for AIDS-related CMV retinitis filed for approval with FDA

Recent patent covers new inhibitors of specific MMPs

Phosphoric acid derivatives useful for inflammatory disorders

Macrolide immunomodulators in the Abbott pipeline

Novel series of antimicrobial compounds identified by National Science Council

Roche discloses new NK1 antagonists and their therapeutic applications

Antitumor agents patented by Japanese researchers

Potentially safe and effective treatments for multiple sclerosis discovered at Active Biotech

Novel serotonergic agents from Sankyo and their use in CNS disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...